Ahrens Investment Partners LLC grew its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 431.0% in the first quarter, HoldingsChannel reports. The fund owned 86,550 shares of the real estate investment trust’s stock after acquiring an additional 70,250 shares during the period. Medical Properties Trust makes up 0.9% of Ahrens Investment Partners LLC’s portfolio, making the stock its 29th largest position. Ahrens Investment Partners LLC’s holdings in Medical Properties Trust were worth $1,842,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Fieldpoint Private Securities LLC acquired a new stake in shares of Medical Properties Trust in the 4th quarter valued at approximately $26,000. AdvisorNet Financial Inc boosted its holdings in shares of Medical Properties Trust by 80.0% in the 4th quarter. AdvisorNet Financial Inc now owns 1,197 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 532 shares during the last quarter. DB Wealth Management Group LLC acquired a new stake in shares of Medical Properties Trust in the 4th quarter valued at approximately $30,000. Liberty Wealth Management LLC acquired a new stake in shares of Medical Properties Trust in the 4th quarter valued at approximately $32,000. Finally, Meeder Asset Management Inc. boosted its holdings in shares of Medical Properties Trust by 105.6% in the 1st quarter. Meeder Asset Management Inc. now owns 1,571 shares of the real estate investment trust’s stock valued at $33,000 after buying an additional 807 shares during the last quarter. 80.17% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have recently commented on the company. Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 price objective (down previously from $24.00) on shares of Medical Properties Trust in a report on Monday, May 10th. Zacks Investment Research downgraded Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Wednesday, April 21st. TheStreet upgraded Medical Properties Trust from a “c+” rating to a “b” rating in a research note on Thursday, April 29th. KeyCorp increased their price target on Medical Properties Trust from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Thursday, January 21st. Finally, Barclays increased their price target on Medical Properties Trust from $23.00 to $25.00 and gave the company an “overweight” rating in a research note on Monday, February 8th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $22.90.
Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings data on Thursday, April 29th. The real estate investment trust reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.14). The firm had revenue of $362.77 million for the quarter, compared to the consensus estimate of $347.16 million. Medical Properties Trust had a return on equity of 6.60% and a net margin of 38.50%. The firm’s quarterly revenue was up 23.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.37 EPS. On average, equities research analysts predict that Medical Properties Trust, Inc. will post 1.57 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Thursday, April 8th. Investors of record on Thursday, March 18th were given a $0.28 dividend. The ex-dividend date was Wednesday, March 17th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 5.38%. This is a boost from Medical Properties Trust’s previous quarterly dividend of $0.27. Medical Properties Trust’s dividend payout ratio (DPR) is presently 86.15%.
In related news, CFO R Steven Hamner sold 250,000 shares of the firm’s stock in a transaction dated Wednesday, February 24th. The stock was sold at an average price of $22.49, for a total value of $5,622,500.00. Following the sale, the chief financial officer now directly owns 1,792,688 shares of the company’s stock, valued at $40,317,553.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Edward K. Aldag, Jr. sold 710,000 shares of the firm’s stock in a transaction dated Tuesday, March 30th. The shares were sold at an average price of $21.21, for a total value of $15,059,100.00. Following the completion of the sale, the chief executive officer now directly owns 3,251,167 shares in the company, valued at $68,957,252.07. The disclosure for this sale can be found here. Insiders sold 993,000 shares of company stock worth $21,385,160 in the last 90 days. 1.18% of the stock is owned by company insiders.
Medical Properties Trust Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.
Recommended Story: What is the Coverage Ratio?
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.